Benzimidazole → HCID 67351942, compound
Reaction equation
[N:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[NH:3][CH:2]=1.[CH2:10]([C:12]1[CH:17]=[CH:16][C:15]([C:18]#[C:19][C:20]([O:22][CH2:23][CH3:24])=[O:21])=[CH:14][CH:13]=1)[CH3:11].C(=O)([O-])[O-].[K+].[K+]>CN(C=O)C>[N:1]1([C:18]([C:15]2[CH:16]=[CH:17][C:12]([CH2:10][CH3:11])=[CH:13][CH:14]=2)=[CH:19][C:20]([O:22][CH2:23][CH3:24])=[O:21])[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[CH:2]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 100 °C
Procedure
To a solution of benzimidazole (118 mg, 1.00 mmol) in DMF (3 mL) was added ethyl 3-(4-ethylphenyl)-2-propynoate (202 mg, 1.00 mmol) and potassium carbonate (152 mg, 1.10 mmol). This suspension was heated to 100° C. for 48 hours, then cooled to room temperature, and evaporated in vacuo. The residue was partitioned between water and dichloromethane, and the separated aqueous layer extracted with dichloromethane. The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and evaporated in vacuo. The residue was purified by flash column chromatography on silica gel, eluting with a mixture of dichloromethane and methanol (96:4) to afford (in order of elution), ethyl (2Z)-3-(1H-benzimidazol-1-yl)-3-(4-ethylphenyl)-2-propenoate, mixed fractions, and ethyl (2E)-3-(1H-benzimidazol-1-yl)-3-(4-ethylphenyl)-2-propenoate.
Workup
- temperaturecooled to room temperature
- customevaporated in vacuo
- customThe residue was partitioned between water and dichloromethane
- extractionthe separated aqueous layer extracted with dichloromethane
- dry with materialThe combined organic layers were dried over anhydrous magnesium sulfate
- filtrationfiltered
- customevaporated in vacuo
- customThe residue was purified by flash column chromatography on silica gel
- washeluting with a mixture of dichloromethane and methanol (96:4)
- customto afford
- wash(in order of elution), ethyl (2Z)-3-(1H-benzimidazol-1-yl)-3-(4-ethylphenyl)-2-propenoate
- additionmixed fractions, and ethyl (2E)-3-(1H-benzimidazol-1-yl)-3-(4-ethylphenyl)-2-propenoate
Sources & evidence
- ORD record
- ord-60aee5917fe04ece842761384ea8809e
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003806B2
Reaction notes
Loading…